TY - JOUR
T1 - Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis
AU - Barak, V.
AU - Selmi, C.
AU - Schlesinger, M.
AU - Blank, M.
AU - Agmon-Levin, N.
AU - Kalickman, I.
AU - Gershwin, M. E.
AU - Shoenfeld, Y.
PY - 2009/11
Y1 - 2009/11
N2 - Primary biliary cirrhosis (PBC) is a chronic cholestatic autoimmune liver disease characterized by selective destruction of the intrahepatic bile ducts and highly specific serum anti-mitochondrial autoantibodies (AMA). Several studies have attempted to determine the cytokine pattern characterizing PBC, yet no definitive data have been gathered. The present study was designed to evaluate pro-inflammatory cytokines (IL-1β, IL-6, TNFα), soluble IL-2 receptor (sIL-2R, e.g. soluble CD25), and complement components (C1q, C3, factor B, properdin) levels in sera from 84 patients with PBC and 41 controls. PBC was characterized by significantly higher levels of all pro-inflammatory cytokines when compared to controls; these included IL-1β (433.3 ± 13.2 vs. 316.6 ± 14.7 pg/ml, P
AB - Primary biliary cirrhosis (PBC) is a chronic cholestatic autoimmune liver disease characterized by selective destruction of the intrahepatic bile ducts and highly specific serum anti-mitochondrial autoantibodies (AMA). Several studies have attempted to determine the cytokine pattern characterizing PBC, yet no definitive data have been gathered. The present study was designed to evaluate pro-inflammatory cytokines (IL-1β, IL-6, TNFα), soluble IL-2 receptor (sIL-2R, e.g. soluble CD25), and complement components (C1q, C3, factor B, properdin) levels in sera from 84 patients with PBC and 41 controls. PBC was characterized by significantly higher levels of all pro-inflammatory cytokines when compared to controls; these included IL-1β (433.3 ± 13.2 vs. 316.6 ± 14.7 pg/ml, P
KW - Autoimmune cholangitis
KW - Cytokines
KW - PBC
KW - Serum markers
KW - T regulatory cells
UR - http://www.scopus.com/inward/record.url?scp=71649095850&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71649095850&partnerID=8YFLogxK
U2 - 10.1016/j.jaut.2009.09.010
DO - 10.1016/j.jaut.2009.09.010
M3 - Article
C2 - 19846277
AN - SCOPUS:71649095850
VL - 33
SP - 178
EP - 182
JO - Journal of Autoimmunity
JF - Journal of Autoimmunity
SN - 0896-8411
IS - 3-4
ER -